{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:50:21Z","timestamp":1791931821389,"version":"4.3.4"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K22CA258953"],"award-info":[{"award-number":["K22CA258953"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.celrep.2026.116928","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:08:50Z","timestamp":1769206130000},"page":"116928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oncogenic influences of neurotrophin receptors: Shedding light on Trk biology"],"prefix":"10.1016","volume":"45","author":[{"given":"Hawa L.","family":"Jagana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam M.","family":"Shabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor S.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hemenway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visakha","family":"Mukkamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lukasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-3139","authenticated-orcid":false,"given":"Siobhan S.","family":"Pattwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.116928_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/350158a0","article-title":"Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF","volume":"350","author":"Kaplan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.116928_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/319743a0","article-title":"A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences","volume":"319","author":"Martin-Zanca","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.116928_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jnc.15617","article-title":"Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC","volume":"161","author":"Ateaque","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2026.116928_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2019.100657","article-title":"Future considerations for pediatric cancer survivorship: Translational perspectives from developmental neuroscience","volume":"38","author":"Jones","year":"2019","journal-title":"Dev. Cogn. Neurosci."},{"key":"10.1016\/j.celrep.2026.116928_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.903560306","article-title":"Expression of trk receptors in the developing and adult human central and peripheral nervous system","volume":"356","author":"Muragaki","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.celrep.2026.116928_bib7","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12026-010-8187-5","article-title":"Role of Ras\/Raf\/MEK\/ERK signaling in physiological hematopoiesis and leukemia development","volume":"49","author":"Chung","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.celrep.2026.116928_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77455","article-title":"BDNF\/TrkB signaling endosomes in axons coordinate CREB\/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons","volume":"12","author":"Moya-Alvarado","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.116928_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1009404","article-title":"PLC-\u03b3-Ca2+ pathway regulates axonal TrkB endocytosis and is required for long-distance propagation of BDNF signaling","volume":"17","author":"Moya-Alvarado","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.celrep.2026.116928_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.celrep.2026.116928_bib12","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1073\/pnas.2336152100","article-title":"Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway","volume":"100","author":"Yamauchi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116928_bib13","doi-asserted-by":"crossref","first-page":"viii5","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","article-title":"Targeting TRK family proteins in cancer","volume":"173","author":"Khotskaya","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2026.116928_bib15","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1242\/dev.008227","article-title":"Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development","volume":"134","author":"Bartkowska","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.celrep.2026.116928_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/humu.22688","article-title":"Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart disease","volume":"35","author":"Werner","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.celrep.2026.116928_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41420-023-01615-7","article-title":"The Neurod1\/4-Ntrk3-Src pathway regulates gonadotrope cell adhesion and motility","volume":"9","author":"Le Cicl\u00e9","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.celrep.2026.116928_bib18","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1523\/JNEUROSCI.17-18-07007.1997","article-title":"Trk receptors function as rapid retrograde signal carriers in the adult nervous system","volume":"17","author":"Bhattacharyya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2026.116928_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1447-073X.2005.00120.x","article-title":"Expression of p75NTR and Trk neurotrophin receptors in the enteric nervous system of human adults","volume":"80","author":"Kondyli","year":"2005","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.celrep.2026.116928_bib20","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1073\/pnas.061020198","article-title":"Activation of Trk neurotrophin receptors in the absence of neurotrophins","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116928_bib21","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.0709102105","article-title":"Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect","volume":"105","author":"Jeanneteau","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116928_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/dneu.22592","article-title":"Differential effects of transient and sustained activation of BDNF-TrkB signaling","volume":"78","author":"Guo","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.celrep.2026.116928_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1471-4159.2004.02568.x","article-title":"Autocrine regulation of nerve growth factor expression by Trk receptors","volume":"90","author":"Mallei","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celrep.2026.116928_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44667","article-title":"Astrocyte morphogenesis is dependent on BDNF signaling via astrocytic TrkB.T1","volume":"8","author":"Holt","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.116928_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","article-title":"Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment","volume":"103","author":"Geraghty","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2026.116928_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70198","article-title":"Insulin Receptor Regulates Neurotrophin and Neurotrophin Receptor Expression in the Differentiation of Neural Stem Cells: In Vitro Study","volume":"39","author":"Langhnoja","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.celrep.2026.116928_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120982","article-title":"Electrical stimulation of human neural stem cells via conductive polymer nerve guides enhances peripheral nerve recovery","volume":"275","author":"Song","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.celrep.2026.116928_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00183","article-title":"Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics","volume":"2","author":"Okamura","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2025.100305","article-title":"Unraveling the role of perineural invasion in cancer-associated pain: Insights and treatment strategies","volume":"10","author":"Catalano","year":"2025","journal-title":"Curr. Res. Biotechnol."},{"key":"10.1016\/j.celrep.2026.116928_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.116928_bib31","article-title":"Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide","volume":"35","author":"Chernov","year":"2020","journal-title":"Drug Metab. Pers. Ther."},{"key":"10.1016\/j.celrep.2026.116928_bib32","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/cas.15354","article-title":"Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells","volume":"113","author":"Suzuki","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.celrep.2026.116928_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110204","article-title":"The engagement of Ras\/Raf\/MEK\/ERK and PLC\u03b31\/PKC pathways regulated by TrkB receptor in resistance of glioma cells to elimination upon apoptosis induction","volume":"262","author":"Zaj\u0105c","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.celrep.2026.116928_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/20450907.2025.2558455","article-title":"Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma","volume":"14","author":"Balasubramanian","year":"2025","journal-title":"CNS Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114829","article-title":"ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models","volume":"43","author":"Schmid","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib36","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1007\/s11033-020-05739-2","article-title":"Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma","volume":"47","author":"Pinheiro","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152017","article-title":"TRKB acts as a prognostic predictive marker in Her-2 positive breast cancer","volume":"60","author":"Zhang","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.116928_bib39","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-020-16786-5","article-title":"A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways","volume":"11","author":"Pattwell","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116928_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4193541","article-title":"Full-Length TrkB Variant in NSCLC Is Associated with Brain Metastasis","volume":"2020","author":"Lombardi","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.celrep.2026.116928_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo6789","article-title":"Oncogenic role of a developmentally regulated NTRK2 splice variant","volume":"8","author":"Pattwell","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.116928_bib42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","article-title":"Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.116928_bib43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-022-05219-4","article-title":"The MBNL1\/circNTRK2\/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.116928_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2004.09.011","article-title":"TrkA alternative splicing","volume":"6","author":"Tacconelli","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.116928_bib45","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.3390\/ijms25105475","article-title":"Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells","volume":"25","author":"Cappabianca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.116928_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-018-0786-3","article-title":"The oncogenic neurotrophin receptor tropomyosin-related kinase variant TrkIII","volume":"37","author":"Farina","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116928_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/pbc.23343","article-title":"Clinical significance of NTRK family gene expression in neuroblastomas","volume":"59","author":"Light","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib48","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-04-3606","article-title":"Genetic and Pharmacologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor\/TrkB Rescue of Neuroblastoma Cells from Chemotherapy-Induced Cell Death","volume":"65","author":"Li","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.116928_bib49","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1074\/jbc.274.23.16451","article-title":"Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells","volume":"274","author":"Middlemas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.116928_bib50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/cells12040544","article-title":"The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN","volume":"12","author":"Ando","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2026.116928_bib51","series-title":"MYCN inhibits TrkC-mediated differentiation in neuroblastoma cells via disruption of the PKA signalling pathway","author":"Maher","year":"2024"},{"key":"10.1016\/j.celrep.2026.116928_bib52","first-page":"1009","article-title":"Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas","volume":"30","author":"Chen-Tsai","year":"2004","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.celrep.2026.116928_bib53","first-page":"477","article-title":"Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma","volume":"8","author":"Sakamoto","year":"2001","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib54","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/stem.1661","article-title":"Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors","volume":"32","author":"Sidney","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.celrep.2026.116928_bib55","first-page":"299","article-title":"Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors","volume":"49","author":"Weiss","year":"1983","journal-title":"Lab. Invest."},{"key":"10.1016\/j.celrep.2026.116928_bib56","first-page":"4705","article-title":"A novel ETV6-NTRK3 gene fusion in primary renal fibrosarcoma","volume":"26","author":"Jiang","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.celrep.2026.116928_bib57","article-title":"Recurrent SPECC1L-NTRK fusions in pediatric sarcoma and brain tumors","volume":"6","author":"Khuong-Quang","year":"2020","journal-title":"Cold Spring Harbor Case Stud."},{"key":"10.1016\/j.celrep.2026.116928_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00432-024-06042-4","article-title":"NTRK-rearranged spindle cell tumor with SPECC1L-NTRK3 fusion in the thoracic spine: a case report","volume":"151","author":"Zhou","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PGP.0000000000001014","article-title":"SMARCB1 (INI1) Deficient Tumours of the Uterine Cervix: Report of Two Cases, Including One Associated With an NTRK Fusion","volume":"43","author":"Razack","year":"2024","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00428-024-03829-1","article-title":"CD34\/S100 protein-positive, NTRK1-rearranged infantile fibrosarcoma-like tumors in genitourinary system: two cases expanding the clinicopathologic spectrum and illustrating the diagnostic dilemma","volume":"485","author":"Zhao","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.celrep.2026.116928_bib61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/PAS.0000000000002202","article-title":"Primary NTRK -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases","volume":"48","author":"Gao","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib62","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PGP.0000000000000988","article-title":"Uterine Neurotrophic Tyrosine Receptor Kinase Rearranged Spindle Cell Neoplasms: Three Cases of an Emerging Entity","volume":"43","author":"Grant","year":"2024","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896920927467","article-title":"A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications","volume":"29","author":"Rekhi","year":"2021","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/path.6282","article-title":"Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell model","volume":"263","author":"Chen","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib65","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cup.13772","article-title":"LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans","volume":"48","author":"Panse","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib66","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1066896920905888","article-title":"Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors","volume":"28","author":"So","year":"2020","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00428-023-03724-1","article-title":"NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion","volume":"484","author":"Szalai","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.celrep.2026.116928_bib68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12957-021-02237-y","article-title":"Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment","volume":"19","author":"Chen","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib69","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00432-022-04249-x","article-title":"A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma","volume":"148","author":"Bai","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610423","article-title":"NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects","volume":"28","author":"Siozopoulou","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.celrep.2026.116928_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/pin.13499","article-title":"Soft tissue tumor with BRAF and NRAS mutations sharing features with NTRK-rearranged spindle cell neoplasm: A case report expanding the spectrum of spindle cell tumor with kinase gene alterations","volume":"75","author":"Kakuda","year":"2025","journal-title":"Pathol. Int."},{"key":"10.1016\/j.celrep.2026.116928_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100083","article-title":"Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions","volume":"36","author":"Kojima","year":"2023","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib73","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/gcc.23179","article-title":"FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and \u201cNTRK-rearranged\u201d spindle cell neoplasms","volume":"62","author":"Warmke","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib74","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","article-title":"Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions","volume":"34","author":"Br\u010di\u0107","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/his.14069","article-title":"NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma","volume":"77","author":"Rabban","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.celrep.2026.116928_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cjp2.158","article-title":"NTRK fusions in osteosarcoma are rare and non-functional events","volume":"6","author":"Ameline","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.celrep.2026.116928_bib77","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41419-022-05275-w","article-title":"TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.116928_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41379-020-0495-2","article-title":"NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations","volume":"33","author":"Kao","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611993","article-title":"NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas","volume":"30","author":"Lippai","year":"2025","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.celrep.2026.116928_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114005","article-title":"A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas","volume":"202","author":"Lippai","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1329409","article-title":"From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis","volume":"15","author":"Cui","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.celrep.2026.116928_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12967-021-02740-6","article-title":"Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer","volume":"19","author":"Chen","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2026.116928_bib83","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41374-022-00736-4","article-title":"Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p\/TrkB axis","volume":"102","author":"Xing","year":"2022","journal-title":"Lab. Invest."},{"key":"10.1016\/j.celrep.2026.116928_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2019.12.015","article-title":"Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib","volume":"472","author":"Lin","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.116928_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-024-01875-4","article-title":"Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.116928_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107994","article-title":"Inhibition of MEK1\/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer","volume":"32","author":"Vaishnavi","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200190","article-title":"Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer","volume":"6","author":"Doan","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.celrep.2026.116928_bib88","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41388-021-01691-y","article-title":"Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells","volume":"40","author":"Wu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.116928_bib89","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/biom10091329","article-title":"The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer","volume":"10","author":"Griffin","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.celrep.2026.116928_bib90","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1111\/jcmm.15265","article-title":"NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K\/AKT\/GSK signal pathway","volume":"24","author":"Jiang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.celrep.2026.116928_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","article-title":"Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling","volume":"31","author":"Hayakawa","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.116928_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","article-title":"\u03b22 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer","volume":"33","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.116928_bib93","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1073\/pnas.1916833117","article-title":"Immunity against cancer cells may promote their proliferation and metastasis","volume":"117","author":"Lin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116928_bib94","article-title":"A new immunochemical strategy for triple-negative breast cancer therapy","volume":"11","author":"Lin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib95","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-022-05298-3","article-title":"TrkC-mediated inhibition of DJ-1 degradation is essential for direct regulation of pathogenesis of hepatocellular carcinoma","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.116928_bib96","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1159\/000539815","article-title":"Neurotrophin-3 Facilitates Stemness Properties and Associates with Poor Survival in Lung Cancer","volume":"114","author":"Peng","year":"2024","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.celrep.2026.116928_bib97","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41379-020-00678-6","article-title":"Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes","volume":"34","author":"de la Fouchardi\u00e8re","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2026.116928_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219589120","article-title":"Phase separation underlies signaling activation of oncogenic NTRK fusions","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116928_bib99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12688\/f1000research.131013.1","article-title":"Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach","volume":"12","author":"M Al-Subaie","year":"2023","journal-title":"F1000Res."},{"key":"10.1016\/j.celrep.2026.116928_bib100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019003691","article-title":"Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms","volume":"135","author":"Joshi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.116928_bib101","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.7150\/thno.50571","article-title":"KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2026.116928_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69307-1","article-title":"BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells","volume":"10","author":"Talbot","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib103","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41416-021-01611-7","article-title":"CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles","volume":"125","author":"Aitamer","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib104","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/s41467-020-16434-y","article-title":"Evolution and structure of clinically relevant gene fusions in multiple myeloma","volume":"11","author":"Foltz","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116928_bib105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/ml200261d","article-title":"Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models","volume":"3","author":"Albaugh","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.celrep.2026.116928_bib106","first-page":"2039","article-title":"Trk inhibitor GNF-5837 suppresses the tumor growth, survival and migration of renal cell carcinoma","volume":"42","author":"Chen","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.celrep.2026.116928_bib107","series-title":"Recent Results in Cancer Research","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-319-91442-8_10","article-title":"Larotrectinib (LOXO-101).","volume":"211","author":"Berger","year":"2018"},{"key":"10.1016\/j.celrep.2026.116928_bib108","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1002\/cncr.31701","article-title":"The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas","volume":"124","author":"DuBois","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib109","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1\/2 study","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib110","doi-asserted-by":"crossref","first-page":"viii31","DOI":"10.1093\/annonc\/mdz382","article-title":"Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion","volume":"30","author":"Bielack","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100734","article-title":"Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib","volume":"45","author":"Kummar","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.celrep.2026.116928_bib113","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/neuonc\/noab274","article-title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","volume":"24","author":"Doz","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib114","doi-asserted-by":"crossref","first-page":"967","DOI":"10.20892\/j.issn.2095-3941.2023.0471","article-title":"Current therapeutic landscape and resistance mechanisms to larotrectinib","volume":"20","author":"Xie","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.celrep.2026.116928_bib115","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1021\/acs.jmedchem.6b00064","article-title":"Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor","volume":"59","author":"Menichincheri","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celrep.2026.116928_bib116","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib117","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/neuonc\/noac087","article-title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)","volume":"24","author":"Desai","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2026.116928_bib118","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.18632\/oncotarget.24488","article-title":"Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors","volume":"9","author":"Konicek","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2026.116928_bib119","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1158\/1538-7445.AM2017-3161","article-title":"Abstract 3161: TPX-0005, an ALK\/ROS1\/TRK inhibitor, overcomes multiple resistance mechanisms by targeting SRC\/FAK signaling","volume":"77","author":"Zhai","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.116928_bib120","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) Is a Next-Generation ROS1\/TRK\/ALK Inhibitor That Potently Inhibits ROS1\/TRK\/ALK Solvent- Front Mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.116928_bib121","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1158\/1535-7163.MCT-21-0632","article-title":"Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations","volume":"20","author":"Murray","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.116928_bib122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa2302299","article-title":"Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer","volume":"390","author":"Drilon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.116928_bib123","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","article-title":"A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.116928_bib124","doi-asserted-by":"crossref","first-page":"478","DOI":"10.6004\/jnccn.2021.7022","article-title":"Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib","volume":"19","author":"Florou","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.celrep.2026.116928_bib125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/B:DRUG.0000036687.26604.8c","article-title":"Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors","volume":"22","author":"Undevia","year":"2004","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.celrep.2026.116928_bib126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:DRUG.0000047103.64335.b0","article-title":"Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor","volume":"23","author":"Marshall","year":"2005","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.celrep.2026.116928_bib127","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00280-011-1581-4","article-title":"Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study","volume":"68","author":"Minturn","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.celrep.2026.116928_bib128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13063-017-1812-z","article-title":"Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial","volume":"18","author":"Cranston","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.celrep.2026.116928_bib129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamadermatol.2018.1610","article-title":"Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial","volume":"154","author":"Danilenko","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.celrep.2026.116928_bib130","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1038\/onc.2011.133","article-title":"Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours","volume":"30","author":"Rajan","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.116928_bib131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41416-024-02760-1","article-title":"Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents","volume":"131","author":"Roa","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.116928_bib132","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41375-021-01177-6","article-title":"FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children\u2019s Oncology Group trial AALL0631","volume":"35","author":"Brown","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2026.116928_bib133","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1158\/1535-7163.MCT-21-0126","article-title":"Translational Strategies for Repotrectinib in Neuroblastoma","volume":"20","author":"O\u2019Donohue","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.116928_bib134","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpharm.2016.10.057","article-title":"Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion","volume":"515","author":"Shargh","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.celrep.2026.116928_bib135","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s10495-024-01936-7","article-title":"Novel CAR-T cells targeting TRKB for the treatment of solid cancer","volume":"29","author":"Liang","year":"2024","journal-title":"Apoptosis"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:56:28Z","timestamp":1777092988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2211124726000069"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.116928","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogenic influences of neurotrophin receptors: Shedding light on Trk biology","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.116928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116928"}}